These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 30950680)
1. Comparative Study Between Topical Gatifloxacin 0.5% and Moxifloxacin 0.5% as a Prophylactic Measure Before Intraocular Surgery. Abdel-Meguid AAE; Gabr AF; Said MM; Nassef MAEH; Elmenofy TMI J Ocul Pharmacol Ther; 2019 Jun; 35(5):315-318. PubMed ID: 30950680 [No Abstract] [Full Text] [Related]
2. Efficacy and Safety of 0.6% Pazufloxacin Ophthalmic Solution Versus Moxifloxacin 0.5% and Gatifloxacin 0.5% in Subjects with Bacterial Conjunctivitis: A Randomized Clinical Trial. Baiza-Durán L; Olvera-Montaño O; Mercado-Sesma AR; Oregon-Miranda AA; Lizárraga-Corona A; Ochoa-Tabares JC; Pérez-Balbuena AL; Montoya-Sánchez IM; Saucedo-Rodríguez LR; Mora-González A; Gómez-Bastar PA; Villanueva-Najera MA; Sandoval-Delgadillo LI; González-Lomelí M; Páez-Garza JH; Orozco-Carroll M; Casillas-Magallanes M J Ocul Pharmacol Ther; 2018 Apr; 34(3):250-255. PubMed ID: 29624493 [TBL] [Abstract][Full Text] [Related]
3. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. McCulley JP; Caudle D; Aronowicz JD; Shine WE Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244 [TBL] [Abstract][Full Text] [Related]
4. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Kim DH; Stark WJ; O'Brien TP; Dick JD Ophthalmology; 2005 Nov; 112(11):1992-6. PubMed ID: 16183125 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial efficacy of prophylactic gatifloxacin 0.3% and moxifloxacin 0.5% in patients undergoing phacoemulsification surgery. Bucci FA; Amico LM; Evans RE Eye Contact Lens; 2008 Jan; 34(1):39-42. PubMed ID: 18180682 [TBL] [Abstract][Full Text] [Related]
6. Aqueous humor concentrations of topical fluoroquinolones alone or in combination with a steroid. Gomes RLR; Viana RG; Melo LAS; Cruz AC; Lima AAS; Suenaga EM; Campos M Arq Bras Oftalmol; 2017; 80(5):300-303. PubMed ID: 29160540 [TBL] [Abstract][Full Text] [Related]
7. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Costello P; Bakri SJ; Beer PM; Singh RJ; Falk NS; Peters GB; Melendez JA Retina; 2006 Feb; 26(2):191-5. PubMed ID: 16467677 [TBL] [Abstract][Full Text] [Related]
8. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given by different methods before cataract surgery. Ong-Tone L J Cataract Refract Surg; 2007 Jan; 33(1):59-62. PubMed ID: 17189794 [TBL] [Abstract][Full Text] [Related]
9. Human aqueous humor concentrations of besifloxacin, moxifloxacin, and gatifloxacin after topical ocular application. Donnenfeld ED; Comstock TL; Proksch JW J Cataract Refract Surg; 2011 Jun; 37(6):1082-9. PubMed ID: 21596251 [TBL] [Abstract][Full Text] [Related]
10. In vitro efficacy and pharmacodynamic indices for antibiotics against coagulase-negative staphylococcus endophthalmitis isolates. Harper T; Miller D; Flynn HW Ophthalmology; 2007 May; 114(5):871-5. PubMed ID: 17383732 [TBL] [Abstract][Full Text] [Related]
11. Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. Solomon R; Donnenfeld ED; Perry HD; Snyder RW; Nedrud C; Stein J; Bloom A Ophthalmology; 2005 Mar; 112(3):466-9. PubMed ID: 15745775 [TBL] [Abstract][Full Text] [Related]
12. Aqueous Humor Penetration and Biological Activity of Moxifloxacin 0.5% Ophthalmic Solution Alone or with Dexamethasone 0.1. Gomes RL; Viana RG; Melo LA; Cruz AC; Suenaga EM; Kenyon KR; Campos M J Ocul Pharmacol Ther; 2017 Mar; 33(2):98-102. PubMed ID: 28231036 [TBL] [Abstract][Full Text] [Related]
13. Aqueous humour penetration of moxifloxocin and gatifloxacin eye drops in different dosing regimens before phacoemulsification surgery. Güngör SG; Akova YA; Bozkurt A; Yasar Ü; Babaoğlu MÖ; Çetinkaya A; Çolak M Br J Ophthalmol; 2011 Sep; 95(9):1272-5. PubMed ID: 21030410 [TBL] [Abstract][Full Text] [Related]
14. Rate of bacterial eradication by ophthalmic solutions of fourth-generation fluoroquinolones. Callegan MC; Novosad BD; Ramadan RT; Wiskur B; Moyer AL Adv Ther; 2009 Apr; 26(4):447-54. PubMed ID: 19381523 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis. Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203 [TBL] [Abstract][Full Text] [Related]
16. Aqueous humor penetration of gatifloxacin and moxifloxacin eyedrops given in different concentrations in a wick before cataract surgery. Ong-Tone L J Cataract Refract Surg; 2008 May; 34(5):819-22. PubMed ID: 18471639 [TBL] [Abstract][Full Text] [Related]
17. Ocular penetration of moxifloxacin 0.5% and gatifloxacin 0.3% ophthalmic solutions into the aqueous humor following topical administration prior to routine cataract surgery. Kim DH; Stark WJ; O'Brien TP Curr Med Res Opin; 2005 Jan; 21(1):93-4. PubMed ID: 15881479 [TBL] [Abstract][Full Text] [Related]
18. Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures. Fintelmann RE; Hoskins EN; Lietman TM; Keenan JD; Gaynor BD; Cevallos V; Acharya NR Arch Ophthalmol; 2011 Apr; 129(4):399-402. PubMed ID: 21482865 [TBL] [Abstract][Full Text] [Related]
19. Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis. Haugen B; Werner L; Romaniv N; Haymore J; Kleinmann G; Mamalis N; Olson RJ J Cataract Refract Surg; 2008 May; 34(5):853-8. PubMed ID: 18471646 [TBL] [Abstract][Full Text] [Related]
20. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. Deramo VA; Lai JC; Fastenberg DM; Udell IJ Am J Ophthalmol; 2006 Nov; 142(5):721-5. PubMed ID: 16989762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]